Discontinued — last reported Q4 '25
Johnson & Johnson Other Investing decreased by 8.3% to $33.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 106.3%, from $16.00M to $33.00M.
Usually represents minor adjustments; however, large values should be scrutinized for one-time asset disposals or unusual investment activities.
A category capturing miscellaneous cash flows from investing activities that do not fall under capital expenditures, acq...
Standard across most corporate cash flow statements as a balancing category for non-core investing movements.
cf_other_investing| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $101.00M | $59.00M | $12.00M | $5.00M | $81.00M | $16.00M | $72.00M | $30.00M | $36.00M | $33.00M |
| QoQ Change | — | -41.6% | -79.7% | -58.3% | >999% | -80.2% | +350.0% | -58.3% | +20.0% | -8.3% |
| YoY Change | — | -41.6% | -79.7% | — | +575.0% | — | — | +500.0% | -55.6% | +106.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.